Daly Anne
Springfield Diabetes & Endocrine Center, 2528 Farragut Dr, Springfield, IL 62704, USA.
J Am Diet Assoc. 2007 Aug;107(8):1386-93. doi: 10.1016/j.jada.2007.05.004.
The prevalence of diabetes in the United States is increasing at epidemic levels, with over 20.8 million people, or approximately 7.0% of the population, affected. While diabetes is projected to increase by 165% in the next 50 years, many people with diabetes are unable to reach recommended glycemic targets. Although more intensive therapy, often incorporating insulin, is clearly required for many patients, potential side effects, such as weight gain, can deter patients from optimal therapy and undermine the efforts of registered dietitians to improve diabetes self-management. Weight gain occurs following insulin therapy for a number of reasons, including caloric retention because of improved glycemic control; excess caloric intake; decreased caloric expenditure; sedentary lifestyles; and unphysiologic action of conventional insulin formulations. However, weight gain with insulin therapy is not inevitable, and the downward spiral in diabetes management associated with weight gain can be avoided through education and careful attention to therapy regimen. Registered dietitians must be involved before and after initiation of insulin therapy to help patients avoid or minimize weight gain, maximize adherence and glycemic control, and avoid the long-term complications of diabetes.
美国糖尿病患病率正呈流行趋势上升,超过2080万人受影响,约占总人口的7.0%。预计未来50年糖尿病患者人数将增加165%,但许多糖尿病患者无法达到推荐的血糖目标。尽管许多患者显然需要更强化的治疗,通常包括使用胰岛素,但潜在的副作用,如体重增加,可能会阻碍患者接受最佳治疗,并破坏注册营养师改善糖尿病自我管理的努力。胰岛素治疗后体重增加有多种原因,包括血糖控制改善导致热量潴留;热量摄入过多;热量消耗减少;久坐不动的生活方式;以及传统胰岛素制剂的非生理性作用。然而,胰岛素治疗导致体重增加并非不可避免,通过教育和密切关注治疗方案,可以避免与体重增加相关的糖尿病管理恶性循环。在开始胰岛素治疗前后,注册营养师必须参与其中,以帮助患者避免或尽量减少体重增加,最大限度地提高依从性和血糖控制,并避免糖尿病的长期并发症。